Results 171 to 180 of about 1,484,561 (230)

Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection. [PDF]

Antibiotics (Basel)
Klim SM, Prattes J, Amerstorfer F, Niedrist T, Zurl C, Stradner M, Dreo B, Glehr G, Leithner A, Glehr M, Reinbacher P, Sadoghi P, Hauer G.   +12 more
europepmc   +1 more source

The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock. [PDF]

J Clin Lab Anal
Turan C, Yurtseven A, Ozkaya PY, Azarsiz E, Saz EU.   +4 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor as a Predictor of All-Cause Death in Patients Undergoing Coronary Angiography at 10-Year Follow-Up. [PDF]

J Clin Med
Kern A, Stompór T, Bojko K, Sienkiewicz E, Pawlak S, Pawlak K, Pawlak D, Poskrobko G, Andrasz E, Gromadziński L, Jalali R, Onichimowski D, Piwko G, Zalewski A, Bil J.   +14 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS. [PDF]

JHEP Rep
Loosen SH, Benz F, Mohr R, Reuken PA, Wirtz TH, Junker L, Jansen C, Meyer C, Praktiknjo M, Wree A, Reißing J, Demir M, Gu W, Vucur M, Schierwagen R, Stallmach A, Kunstein A, Bode J, Trautwein C, Tacke F, Luedde T, Bruns T, Trebicka J, Roderburg C.   +23 more
europepmc   +1 more source

Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study. [PDF]

Cardiooncology
Chu J, Tung L, Atallah I, Wei C, Cobleigh M, Rao R, Feinstein SB, Usha L, Banach K, Reiser J, Okwuosa TM.   +10 more
europepmc   +1 more source

The Predictive Role of C-Reactive Protein, Leukocyte Cell Count, and Soluble Urokinase Plasminogen Activator Receptor for Pulmonary Sequelae in Hospitalized COVID-19 Survivors: A Prospective Single-Center Cohort Study. [PDF]

J Clin Med
Altintas I, Kallemose T, Lindstrøm MB, Parvaiz I, Rokkedal I, Rasmussen LJ, Iversen KK, Eugen-Olsen J, Iversen KK, Hansen EF, Ulrik CS, Nehlin JO, Andersen O.   +12 more
europepmc   +1 more source

Post-COVID-19 Multisystem Inflammatory Syndrome in Adults (MIS-A) With Elevated Levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Treated With Anakinra: A Case Report. [PDF]

Cureus
Christaki M, Samanidou V, Liontos A, Konstantopoulou R, Milionis H.   +4 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients-a prospective cohort study. [PDF]

Infection
Reisinger AC, Hatzl S, Prattes J, Hackl G, Schilcher G, Eisner F, Niedrist T, Raggam R, Krause R, Eller P.   +9 more
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor (suPAR) is a potential biomarker of stage III-IV, grade C periodontitis through the impact of post-radiotherapy on head and neck cancer patients. [PDF]

BMC Oral Health
Al-Kubaisi AA, Ghazi MA, Majeed NS, Aldelaimi ER, Enezei HH.   +4 more
europepmc   +1 more source

Urokinase-Type Plasminogen Activator Promotes Paracellular Transmigration of Neutrophils via Mac-1, but Independently of Urokinase-Type Plasminogen Activator Receptor [PDF]

Circulation, 2011
Background: Urokinase-type plasminogen activator (uPA) has recently been implicated in the pathogenesis of ischemia-reperfusion (I/R) injury. The underlying mechanisms remain largely unclear.
Johanna Pachmayr, Stefan Lorenzl, Elisabeth Deindl   +2 more
exaly   +2 more sources